Latest Feature

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Kimberly-Clark readies Halyard Health medical device spinout

Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.

HART CEO David Green on the transformative potential for regenerative medicine

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

Podcast: Medtech legends and leaders on the state of medical device innovation

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Acutus Medical pulls in $26M

September 30, 2014 by Alexander Soule

Acutus Medical secured $26.2 million in new funding for its cardiac mapping technology.

Acutus Medical pulls in $26M

Acutus Medical said it secured $26.2 million in new funding for the cardiac mapping technology it's developing to image and map atrial fibrillation hotspots.

Baxter biopharm spinout Baxalta's R&D is Cambridge-bound

September 30, 2014 by Alexander Soule

Baxter International confirmed Cambridge, Mass., as the new R&D hub for Baxalta, the planned spinout of its biopharmaceuticals business.

Baxter biopharm spinout Baxalta's R&D is Cambridge-bound

'Frotox' maker Myoscience raises $8m

September 30, 2014 by Alexander Soule

Myoscience secures $8.4 million in new funding for its 'frotox' device that applies extreme cold to the skin to temporarily treat pain and smooth wrinkles.

'Frotox' maker Myosure raises $8m

Myoscience said it landed $8.4 million of a hoped-for $11.5 million for a device that applies extreme cold to the skin as a way to temporarily treat pain and smooth wrinkles.

What to be wary of in the government's new site detailing industry money to docs

September 30, 2014 by MassDevice

The government's new website on drug and device company ties to doctors will be incomplete and may be misleading - for now.

What to be wary of in the government's new site detailing industry money to docs

David Sleight/ProPublica

by Charles Ornstein, ProPublica

This story was co-published with NPR's Shots blog.

Activist investor erupts at Volcano

September 30, 2014 by Alexander Soule

Activist investor fund Engaged Capital ups the pressure on Volcano Corp., scolding it for its $116 million AtheroMed acquisition and missing chances to sell itself at a premium.

Activist investor erupts at Volcano

FDA releases final recs on legal exemptions for customized medical devices | Regulatory news for the week of September 29, 2014

September 30, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA guides on custom devices; FDA approves Gore's Viabahn for peripheral stent repair; Alcon wins date with FDA panel for AcrySof lens; FDA seeks public input on medtech hacking; ReFlow Medical wins CE Mark for crossing catheters;

FDA guides on custom devices

September 25, 2014 by Alexander Soule

FDA guides on custom devices

In Massachusetts governor's race, the medical device tax has no friends

September 30, 2014 by Brian Johnson

Candidates in the race for Massachusetts governor race tell MassDevice.com that they're for a repeal of the medical device tax and would support exploring a potential offset for Bay State medtech companies.

In Massachusetts governor's race,the medical device tax has no friends

The next Massachusetts governor won't be spending any political capital defending the medical device tax, a 2.3% excise tax on U.S. medtech sales. Both of the leading candidates told MassDevice.com yesterday that they would push for a federal appeal and consider a tax credit to offset the levy.

Studies criticize U.S. medical device approval process

September 29, 2014 by MassDevice

The FDA's less-stringent 510(k) clearance process comes under fire (again) in a pair of new studies.

Studies criticize U.S. medical device approval process

NEW YORK (Reuters Health) - Information on the safety and effectiveness of medical devices before and after they are cleared by U.S. health regulators can be improved, according to 2 new studies.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp